Dade and Cardiovascular Diagnostics form distribution agreement
This article was originally published in Clinica
Executive Summary
Dade International and Cardiovascular Diagnostics have entered into an exclusive, five-year development and distribution agreement for point-of-care haemostasis testing. Under the agreement, Dade will distribute Cardiovascular's Thrombolytic Assessment System (TAS) under a joint label to hospital and non-hospital laboratories. TAS technology includes an analyser and test cards (see Clinica No 693, p 17). The companies estimate that the agreement will result in sales of more than $100 million over the next five years.